Charming Medical Limited Class A Ordinary Shares
NASDAQ:MCTAMedical - Care Facilities
+$0.00 today
- Market cap
- $445.55M
- Beta
- 0.00
- P/E (TTM)
- 414.6
- EPS (TTM)
- $0.07
Volume 0.00M
Average 0.87M
MCTA Total Non-current Liabilities
All obligations due after more than one year.
Charming Medical Limited Class A Ordinary SharesNASDAQ: MCTA
Total Non-current Liabilities · Q4 FY2024 · quarter ended Mar 2025
Total non-current liabilities rises 141.5% from a year ago
Total non-current liabilities stood at $358.03K at the end of Q4 FY2024, up 141.5% from a year earlier.
Context
- Total non-current liabilities amounted to 6.7% of total assets at the end of Q4 FY2024, up 3.6 pp from a year earlier.
- Total non-current liabilities increased in 1 of the last 2 fiscal years.
What to watch
Whether total non-current liabilities keeps rising in the next quarterly balance sheet after a +141.5% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Non-current Liabilities history
USD · from the balance sheet
- Latest · FY2024
- 358.03K USD
- Year-over-year change
- +141.5%
- 2-year CAGR
- -14.0%
| Period | Period end | Total Non-current Liabilities | YoY change |
|---|---|---|---|
| FY2024 | 2025-03-31 | 358.03K | +141.5% |
| FY2023 | 2024-03-31 | 148.25K | -69.4% |
| FY2022 | 2023-03-31 | 484.26K | — |
Total Non-current Liabilities vs competitors
How MCTA compares with its peers on the latest reported figures
- MCTA's Mar 2025 total non-current liabilities of $358.03K is the lowest of the 10 companies compared; the peer median is $18.24M.
- Its year-over-year change of +141.5% is the 2nd highest of 10, against a peer median of -12.7%.
- Total non-current liabilities amounts to 6.7% of total assets for MCTA, versus a peer median of 3.4%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $105.16M | +5.8% | +0.2% | 62.5% | |
| Mar 2026 | $51.18M | -11.6% | -17.6% | 3.4% | |
| Mar 2026 | $47.7M | -2.6% | -39.5% | 10.6% | |
| Mar 2026 | $22.42M | -12.7% | -9.6% | 8.5% | |
| Mar 2026 | $18.24M | -53.5% | -41.2% | 6.7% | |
| Mar 2026 | $9.32M | -15.2% | -38.8% | 3.1% | |
| Mar 2026 | $1.99M | +321.1% | +15.4% | 0.3% | |
| Mar 2026 | $1.43M | -20.6% | -45.4% | 1.1% | |
| Feb 2026 | $370K | -68.7% | -55.1% | 0.3% | |
MCTACharming Medical Limited Class A Ordinary Shares | Mar 2025 | $358.03K | +141.5% | — | 6.7% |
| Peer median (excluding MCTA) | $18.24M | -12.7% | -38.8% | 3.4% | |
Competitors are the stored peer set for MCTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Charming Medical Limited Class A Ordinary Shares
NASDAQ:MCTA
Intrinsic Alpha fair value
Locked
Current Price
$29.36
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.